These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21276938)

  • 1. Peptide length and leaving-group sterics influence potency of peptide phosphonate protease inhibitors.
    Brown CM; Ray M; Eroy-Reveles AA; Egea P; Tajon C; Craik CS
    Chem Biol; 2011 Jan; 18(1):48-57. PubMed ID: 21276938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphonate inhibitors of West Nile virus NS2B/NS3 protease.
    Skoreński M; Milewska A; Pyrć K; Sieńczyk M; Oleksyszyn J
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):8-14. PubMed ID: 30362835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of rhomboid proteases.
    Wolf EV; Verhelst SH
    Biochimie; 2016 Mar; 122():38-47. PubMed ID: 26166068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity based probes for proteases: applications to biomarker discovery, molecular imaging and drug screening.
    Fonović M; Bogyo M
    Curr Pharm Des; 2007; 13(3):253-61. PubMed ID: 17313359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of several small-size HTLV-I protease inhibitors with different hydrophilicity profiles.
    Nguyen JT; Kato K; Hidaka K; Kumada HO; Kimura T; Kiso Y
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2425-9. PubMed ID: 21392990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteases universally recognize beta strands in their active sites.
    Tyndall JD; Nall T; Fairlie DP
    Chem Rev; 2005 Mar; 105(3):973-99. PubMed ID: 15755082
    [No Abstract]   [Full Text] [Related]  

  • 7. The spectrum between substrates and inhibitors: Pinpointing the binding mode of dengue protease ligands with modulated basicity and hydrophobicity.
    Dražić T; Kühl N; Gottscheber N; Hacker CN; Klein CD
    Bioorg Med Chem; 2021 Oct; 48():116412. PubMed ID: 34592636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
    Majerová T; Novotný P; Krýsová E; Konvalinka J
    Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Gemini peptides: cytosolic protease resistance via N-terminal dimerization of unstructured peptides.
    Fayer EL; Gilliland WM; Ramsey JM; Allbritton NL; Waters ML
    Chem Commun (Camb); 2017 Dec; 54(2):204-207. PubMed ID: 29230440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for Tuning the Selectivity of Chemical Probes that Target Serine Hydrolases.
    Faucher F; Bennett JM; Bogyo M; Lovell S
    Cell Chem Biol; 2020 Aug; 27(8):937-952. PubMed ID: 32726586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.
    Franco FM; Jones DE; Harris PK; Han Z; Wildman SA; Jarvis CM; Janetka JW
    Bioorg Med Chem; 2015 May; 23(10):2328-43. PubMed ID: 25882520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
    Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
    J Virol; 2017 May; 91(10):. PubMed ID: 28298600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease.
    Stevens JT; Mapelli C; Tsao J; Hail M; O'Boyle D; Weinheimer SP; Diianni CL
    Eur J Biochem; 1994 Dec; 226(2):361-7. PubMed ID: 8001553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into matriptase-2 substrate binding and inhibition mechanisms by analyzing active-site-mutated variants.
    Maurer E; Sisay MT; Stirnberg M; Steinmetzer T; Bajorath J; Gütschow M
    ChemMedChem; 2012 Jan; 7(1):68-72. PubMed ID: 21919209
    [No Abstract]   [Full Text] [Related]  

  • 15. Design and evaluation of substrate-based octapeptide and non substrate-based tetrapeptide inhibitors of dengue virus NS2B-NS3 proteases.
    Prusis P; Junaid M; Petrovska R; Yahorava S; Yahorau A; Katzenmeier G; Lapins M; Wikberg JE
    Biochem Biophys Res Commun; 2013 May; 434(4):767-72. PubMed ID: 23587903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteochemometrics mapping of the interaction space for retroviral proteases and their substrates.
    Kontijevskis A; Petrovska R; Yahorava S; Komorowski J; Wikberg JE
    Bioorg Med Chem; 2009 Jul; 17(14):5229-37. PubMed ID: 19539482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity profiling of DegP substrates and inhibitors.
    Hauske P; Meltzer M; Ottmann C; Krojer T; Clausen T; Ehrmann M; Kaiser M
    Bioorg Med Chem; 2009 Apr; 17(7):2920-4. PubMed ID: 19233659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal Structures and Inhibition Kinetics Reveal a Two-Stage Catalytic Mechanism with Drug Design Implications for Rhomboid Proteolysis.
    Cho S; Dickey SW; Urban S
    Mol Cell; 2016 Feb; 61(3):329-340. PubMed ID: 26805573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel exosite on coagulation factor VIIa and its molecular interactions with a new class of peptide inhibitors.
    Roberge M; Santell L; Dennis MS; Eigenbrot C; Dwyer MA; Lazarus RA
    Biochemistry; 2001 Aug; 40(32):9522-31. PubMed ID: 11583151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed alkyl aryl phosphonate esters as quenched fluorescent activity-based probes for serine proteases.
    Serim S; Baer P; Verhelst SH
    Org Biomol Chem; 2015 Feb; 13(8):2293-9. PubMed ID: 25553959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.